Correlation Between Pfizer and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and CureVac NV, you can compare the effects of market volatilities on Pfizer and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and CureVac NV.

Diversification Opportunities for Pfizer and CureVac NV

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and CureVac is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Pfizer i.e., Pfizer and CureVac NV go up and down completely randomly.

Pair Corralation between Pfizer and CureVac NV

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the CureVac NV. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.97 times less risky than CureVac NV. The stock trades about -0.23 of its potential returns per unit of risk. The CureVac NV is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  283.00  in CureVac NV on August 28, 2024 and sell it today you would lose (6.00) from holding CureVac NV or give up 2.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  CureVac NV

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pfizer and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and CureVac NV

The main advantage of trading using opposite Pfizer and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Pfizer Inc and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance